Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11286265 Macrocyclic compounds for treating disease

Patent 11286265 was granted and assigned to Turning Point Therapeutics on March, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Turning Point Therapeutics

0

Current Assignee

Turning Point Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Dayong Zhai0

Wei Deng0

Jingrong J. Cui0

Jeffrey Whitten0

Jane Ung0

Han Zhang0

Evan W. Rogers0

Date of Patent

March 29, 2022

0

Patent Application Number

168669830

Date Filed

May 5, 2020

0

Patent Citations

US Patent 10316044 Chiral diaryl macrocycles as modulators of protein kinases

0

US Patent 10246466 Diaryl macrocycles as modulators of protein kinases

0

US Patent 10294242 Diaryl macrocycle polymorph

US Patent 10745416 Macrocyclic compounds for treating disease

Patent Primary Examiner

Noble E Jarrell

0

CPC Code

0

0

0

The present disclosure relates to certain macrocyclic derivatives, pharmaceutical compositions containing them, and methods of using them to treat disease, such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11286265 Macrocyclic compounds for treating disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool